Longaeva Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.43M Buy
+109,222
New +$9.7M 0.19% 128
2026
Q1
– Sell
-259,367
Closed -$22.1M – 220
2025
Q4
$22.1M Buy
259,367
+9,882
+4% +$811K 1.85% 11
2025
Q3
$19.4M Sell
249,485
-7,865
-3% -$615K 2.8% 7
2025
Q2
$20.1M Buy
+257,350
New +$19.2M 4.11% 8

Other funds holding EW

Longaeva Partners's EW Position: Q3 2026 in Review

Longaeva Partners opened a new position in Edwards Lifesciences (EW) in Q3 2026: 109,222 shares worth $9.43M. The stake represents 0.19% of the portfolio and ranks #128 among its holdings. This is a return to the name: Longaeva Partners previously reported a position in EW as recently as Q4 2025.

Longaeva Partners first reported a position in EW in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.1M in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Longaeva Partners held 109,222 shares of Edwards Lifesciences worth $9.43M as of Q3 2026.
  • Edwards Lifesciences was a new Longaeva Partners position in Q3 2026.
  • Edwards Lifesciences made up 0.19% of Longaeva Partners's portfolio in Q3 2026, its #128 holding.
  • Longaeva Partners first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • Longaeva Partners's Edwards Lifesciences position peaked at $22.1M in Q4 2025.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.